Medium-long-term results of using aortic homographs and Bentall procedures in aortic root pathologies: the experience of one center
R. N. Komarov,
M. I. Tkachev,
E. B. Panesh,
G. A. Varlamov,
I. D. Gailaev,
N. C. Choibsonov,
T. A. Maisyan,
D. V. Murylev https://doi.org/10.17238/2072-3180-2025-4-86-93
Abstract
Introduction. Aortic root replacement in young patients requires balancing the durability of mechanical valves with the reduced risk of thromboembolism and bleeding associated with biological implants. Cryopreserved homografts represent a promising alternative to the Bentall procedure.
Objective. To perform a comparative analysis of clinical and valve-related outcomes in patients undergoing elective aortic root replacement using either homografts or mechanical prostheses.
Materials and methods. This retrospective study included 85 patients operated on from 2015 to 2021: 19 patients received cryopreserved homografts (mean age 50,05 ± 16,35 years), and 66 patients underwent the Bentall procedure (mean age 52 ± 14,03 years). The cumulative follow-up was 423 patient-years. Survival rates, hospital and mid-term mortality, and complication rates were analyzed.
Results. Hospital mortality was 2 cases in the Bentall group; no hospital deaths occurred in the homograft group. Mid-term mortality in the Bentall group was 4 cases (one related to valve thrombosis and stroke), while one death in the homograft group was unrelated to the prosthesis. In the Bentall group, bleeding events (n = 5, 7,58 %) and thrombosis (n = 3, 4,5 %) were observed; no such complications occurred in the homograft group. Leaflet stenosis was detected in one homograft patient without clinical significance and without need for reoperation.
Conclusion. Both approaches provide satisfactory outcomes in elective settings. However, homografts showed a more favorable safety profile, including absence of thrombosis, bleeding, and reoperations. This makes them a promising option for young patients, although long-term durability data are needed
About the Authors
R. N. Komarov
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Komarov Roman Nikolaevich – MD, Professor, Head of the Department of Cardiovascular Surgery at the Institute of Professional Education
8 Trubetskaya str., Moscow, 119991
M. I. Tkachev
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Tkachev Maxim Igorevich – PhD, Associate Professor of the Department of Cardiovascular Surgery, Institute of Professional Education
8 Trubetskaya str., building 2, Moscow, 119991
E. B. Panesh
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Panesh Elena Batyrbievna – a 4th–year student
8 Trubetskaya str., building 2, Moscow, 119991
G. A. Varlamov
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Varlamov Georgy Arkadyevich – a 4th–year student
8 Trubetskaya str., building 2, Moscow, 119991
I. D. Gailaev
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Gaylaev Ilyas Danilbekovich – a 5th–year student
8 Trubetskaya str., building 2, Moscow, 119991
N. C. Choibsonov
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Choibsonov Nima-Surun Tsyren-Dashievich – 4th year student
8 Trubetskaya str., building 2, Moscow, 119991
T. A. Maisyan
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Maisyan Tigran Artemovich – 3rd year student
8 Trubetskaya str., building 2, Moscow, 119991
D. V. Murylev
I.M. Sechenov First Moscow State Medical University
Russian Federation
Russian Federation
Murylev Daniil Vadimovich – 4th year student
8 Trubetskaya str., building 2, Moscow, 119991
References
1. Bentall H., De Bono A. A technique for complete replacement of the ascending aorta. Thorax, 1968,№ 23(4), рр. 338–339. https://doi.org/10.1136/thx.23.4.338
2. Etz C.D., Bischoff M.S., Bodian C., et al. The Bentall procedure: is it the gold standard? A series of 597 consecutive cases. J Thorac Cardiovasc Surg., 2010, № 140(6 Suppl), рр. S64–70; discussion S86–91. https://doi.org/10.1016/j.jtcvs.2010.07.033
3. Pantaleo A., Murana G., Di Marco L., et al. Biological versus mechanical Bentall procedure for aortic root replacement: a propensity score analysis of a consecutive series of 1112 patients. Eur J Cardiothorac Surg., 2017, № 52(1), рр. 143–149. https://doi.org/10.1093/ejcts/ezx070
4. Werner P., Gritsch J., Kaider A., et al. Long Term Results of the Modified Bentall Procedure With Mechanical and Biological Composite Valve Grafts. Front Cardiovasc Med., 2022, № 9, рр. 867732. https://doi.org/10.3389/fcvm.2022.867732
5. Goldstone A.B., Chiu P., Baiocchi M., et al. Mechanical or Biologic Prostheses for Aortic-Valve and Mitral-Valve Replacement. N Engl J Med., 2017, № 377(19), рр. 1847–1857. https://doi.org/10.1056/NEJMoa1613792
6. Glaser N., Jackson V., Holzmann M.J., Franco-Cereceda A., Sartipy U. Prosthetic Valve Endocarditis After Surgical Aortic Valve Replacement. Circulation, 2017, № 136(3), рр. 329–331. https://doi.org/10.1161/CIRCULATIONAHA.117.028783
7. Mookhoek A., Korteland N.M., Arabkhani B., et al. Bentall Procedure: A Systematic Review and Meta-Analysis. Ann Thorac Surg., 2016, № 101(5), рр. 1684–1689. https://doi.org/10.1016/j.athoracsur.2015.10.090
8. Tudorache I., Horke A., Cebotari S., et al. Decellularized aortic homografts for aortic valve and aorta ascendens replacement. Eur J Cardiothorac Surg., 2016, № 50(1), рр. 89–97. https://doi.org/10.1093/ejcts/ezw013
9. Horke A., Tudorache I., Laufer G., et al. Early results from a prospective, single-arm European trial on decellularized allografts for aortic valve replacement: the ARISE study and ARISE Registry data. European Journal of Cardio-Thoracic Surgery, 2020, № 58(5), рр. 1045–1053. https://doi.org/10.1093/ejcts/ezaa100
10. Andreeva A., Coti I., Werner P., et al. Aortic Valve Replacement in Adult Patients with Decellularized Homografts: A Single-Center Experience. J Clin Med., 2023, № 12(21), рр. 6713. https://doi.org/10.3390/jcm12216713
11. Coti I., Wenda S., Andreeva A., et al. Donor-specific HLA antibodies after fresh decellularized vs cryopreserved native allograft implantation. HLA, 2020, № 96(5), рр. 580-588. https://doi.org/10.1111/tan.14077
12. Di Marco L., Pacini D., Pantaleo A., et al. Composite valve graft implantation for the treatment of aortic valve and root disease: Results in 1045 patients. J Thorac Cardiovasc Surg., 2016, № 152(4), рр. 1041–1048. https://doi.org/10.1016/j.jtcvs.2016.05.021
13. Zehr K.J., Yagubyan M, Connolly HM, Nelson SM, Schaff HV. Aortic root replacement with a novel decellularized cryopreserved aortic homograft: postoperative immunoreactivity and early results. J Thorac Cardiovasc Surg., 2005, № 130(4), рр. 1010–1015. https://doi.org/10.1016/j.jtcvs.2005.03.044
14. Da Costa F.D.A., Costa A.C.B.A., Prestes R., et al. The early and midterm function of decellularized aortic valve allografts. Ann Thorac Surg., 2010, № 90(6), рр. 1854–1860. https://doi.org/10.1016/j.athoracsur.2010.08.022
15. Martinsson A., Nielsen S.J., Milojevic M., et al. Life Expectancy After Surgical Aortic Valve Replacement. J Am Coll Cardiol., 2021, № 78(22), рр. 2147–2157. https://doi.org/10.1016/j.jacc.2021.09.861
16. Thourani V.H., Habib R., Szeto W.Y., et al. Survival After Surgical Aortic Valve Replacement in Low-Risk Patients: A Contemporary Trial Benchmark. Ann Thorac Surg., 2024, № 117(1), рр. 106–112. https://doi.org/10.1016/j.athoracsur.2023.10.006
Review
For citations:
Komarov R.N., Tkachev M.I., Panesh E.B., Varlamov G.A., Gailaev I.D., Choibsonov N.C., Maisyan T.A., Murylev D.V. Medium-long-term results of using aortic homographs and Bentall procedures in aortic root pathologies: the experience of one center. Moscow Surgical Journal. 2025;(4):86-93. (In Russ.) https://doi.org/10.17238/2072-3180-2025-4-86-93
Views:
20
Email this article 